Sunderby sjukhus är ett sjukhus beläget vid Södra Sunderbyn mellan Luleå och Boden, omkring 15 km från centrala Luleå. Det tillhör Region Norrbotten. Sjukhuset är länssjukhus för Region Norrbotten med specialistfunktioner, men också närsjukhus för Bodens kommun och Luleå kommun.

During the past decade, Sunderby hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sunderby hospital" #1 sponsor was "Umeå University" with 8 trials, followed by "Uppsala University" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "BeiGene" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sunderby hospital" #1 collaborator was "Aarhus University Hospital" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Sunderby hospital" are "Chronic Lymphocytic Leukemia" (4 trials), "Multiple Myeloma" (4 trials), "Acute Myeloid Leukemia" (2 trials), "Anesthesia; Adverse Effect" (2 trials) and "Diastolic Dysfunction" (2 trials). Many other conditions were trialed in "Sunderby hospital" in a lesser frequency.

Most popular intervention types in "Sunderby hospital" are "Drug" (26 trials), "Procedure" (10 trials), "Other" (6 trials), "Biological" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (6 trials), "Rituximab" (6 trials), "Bortezomib" (3 trials), "Dexamethasone" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sunderby hospital" are 43 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sunderby hospital". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Sunderby hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sunderby hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".